IM Cannabis (IMCC) Other Operating Expenses (2020 - 2026)
IM Cannabis' (IMCC) quarterly Other Operating Expenses came in at $0.0 in Q1 2026, down 100.0% year-on-year from $5577.5 in Q1 2025, and down 100.0% quarter-over-quarter from $11.2 million in Q4 2025.
IM Cannabis (IMCC) Other Operating Expenses (2020 - 2026) Analysis & Trends
IM Cannabis' Other Operating Expenses history runs 7 years deep, the most recent figure standing at $0.0 for Q1 2026.
- On a quarterly basis, Other Operating Expenses fell 100.0% year-over-year to $0.0 in Q1 2026; TTM through Mar 2026 was $7.9 million, a 16.66% increase from a year earlier, with the FY2025 full-year figure at $8.4 million, up 220.81% from the prior year.
- Other Operating Expenses declined to $0.0 in Q1 2026 per IMCC's latest filing, from $11.2 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $11.2 million in Q4 2025 and bottomed at -$2.7 million in Q2 2025.
- The 5-year median for Other Operating Expenses is $178865.0 (2024), against an average of $1.1 million.
- Biggest YoY gain for Other Operating Expenses was 14010.51% in 2024; the steepest drop was 2525.91% in 2024.
- Year by year, Other Operating Expenses stood at $315308.9 in 2022, then slumped by 121.2% to -$66842.7 in 2023, then surged by 14010.51% to $9.3 million in 2024, then advanced by 20.35% to $11.2 million in 2025, then plunged by 100.0% to $0.0 in 2026.
- Per Business Quant, the three latest IMCC Other Operating Expenses figures stand at $0.0 (Q1 2026), $11.2 million (Q4 2025), and -$530443.6 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 11.19 Mn |
| Sep 30, 2025 | -530,443.55 |
| Jun 30, 2025 | -2.72 Mn |
| Mar 31, 2025 | 5,575.33 |
| Dec 31, 2024 | 9.30 Mn |
| Sep 30, 2024 | 178,865.03 |
| Jun 30, 2024 | -2.68 Mn |
| Mar 31, 2024 | 2.07 Mn |
| Dec 31, 2023 | -66,842.73 |
| Sep 30, 2023 | 145,456.44 |
| Jun 30, 2023 | -101,989.99 |
| Mar 31, 2023 | 190,841.66 |
| Dec 31, 2022 | 315,308.86 |
| Sep 30, 2022 | 490,717.60 |
| Jun 30, 2022 | 574,137.36 |
| Mar 31, 2022 | 918,159.89 |
| Dec 31, 2021 | 1.56 Mn |
| Sep 30, 2021 | 1.10 Mn |
| Jun 30, 2021 | 1.12 Mn |